Comparison between immediate and delay triamcinolone acetonide injection after keloid excision

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

TCTR

Registry ID

TCTR20190216001

Enrollment

Registered

2019-02-16

Start date

2019-02-15

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

keloid keloid&#44

Interventions

immediate TA injection after keloid excision,TA injection 1 week after keloid injection

Experimental Drug,Active Comparator Drug

immediate TA injection,delay 1 week TA injection

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: age more than 18 years old diagnosed keloid by the experience surgeon need to treat with intralesion excision follow by Triamcinolone acetonide injection.

Exclusion criteria

Exclusion criteria: alleric reaction to Triamcinolone acetonide

Design outcomes

Primary

Measure	Time frame
recurrent rate 3 months ruler	—

Secondary

Measure	Time frame
complication 1 month physical examination	—

Countries

THAILAND

Contacts

Public ContactChairat Burusapat

Phramongkutklao hospital and College of Medicine

pataranat@hotmail.com+66813713392

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026